Swot Of Coca-Cola Company

1455 Words6 Pages

Company, 1st October 2017, " America's iconic soda brand is removing the black can Coke Zero from US stores and replacing it with Coke Zero Sugar, sweetened with aspartame, which is meant to taste more like a regular coke. The move aims to make coke more appealing to health-conscious drinkers, but the brands diet offerings has struggled as of late. Diet coke's sales fell 4.3% in 2016."

(6) Coca Cola Company SWOT Analysis, 18th Oct 2017, states:

STRENGTH

Brand Portfolio

Geographic presence

Bottling and distribution operations

WEAKNESS

Lawsuits

Revenue decline

OPPORTUNITIES

Focus on Indian market

Acquisition

Growth in soft drink consumption

Capacity expansion

THREATS

Expansion initiatives by competitors …show more content…

In January 2017, the company's division International Beverages Private Limited opened a bottling plant in Bhaluka, Bangladesh with an investment of US$60 million to produce Coca-Cola, Fanta, Sprite and Kinley water. In December 2016, Coca-Cola opened a new facility in Phnom Penh, Cambodia with an investment of US$100 million to expand its production capacity. In November 2016, Coca-Cola, along with its bottling partner, National Beverage Company (NBC), opened a new bottling plant in Gaza, Palestine with an investment of US$20 …show more content…

Coca-Cola’s business in the US is regulated by the US Food and Drug Administration (FDA) and the US Department of Agriculture (USDA). These agencies oversee compliance with regulations. The sale of the company’s products and their ingredients are subject to the Federal Food, Drug, and Cosmetic Act; the Federal Trade Commission Act; the Lanham Act; state consumer protection laws; competition laws; federal, state and local workplace health and safety laws; various federal, state and local environmental protection laws; and various other federal, state and local statutes and regulations. Outside the US, Coca-Cola business is subject to several regulations and other legal and regulatory requirements. FDA also monitors issues related to safety, manufacturing, logistics, distribution, advertising, labeling and sale of the company’s products. It also recovers costs for the inspection, including re-inspection-related costs from the company, besides levying penalty or fines for noncompliance, which could increase the company’s operating

Open Document